Molecular Medicine Research Group, A. I. Virtanen Institute, University of Eastern Finland, Kuopio, Finland
Biography
Academy Professor Seppo Ylä-Herttuala is a pioneer and international leader in cardiovascular gene therapy. He was the first in the world to apply adenoviral gene transfer to human arteries in 1995. Since then he has developed both gene transfer vectors and production systems and a highly successful research team focusing on angiogenesis, VEGF biology and its clinical applications.
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 